Elevate Health vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

MEDVi beats Elevate Health overall, scoring 7.7/10 vs 7.2/10. MEDVi is more affordable at $179/mo vs $233/mo. Choose Elevate Health for users who want financing options and free lab work with thei. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side look at Elevate Health and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Elevate Health

#44 of 52

7.2/10

Affordable compounded GLP-1 provider with financing options and complimentary lab work for qualifying patients.

Visit Elevate Health

Higher Rated

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	Elevate Health	MEDVi
Our Score	7.2/10	7.7/10
Starting Price	$233/mo	$179/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want financing options and free lab work with their GLP-1 program	Users who want a low entry price with oral and injectable compounded options
Ranking	#44	#20
Get started	Visit Elevate Health	Visit MEDVi

Pros & Cons Compared

Elevate Health

Pros

+Oral semaglutide from $114/mo, one of the lowest prices for any form of semaglutide in the market
+Free blood work included with all GLP-1 programs for baseline health assessment and monitoring
+Buy-now-pay-later financing via Affirm, Klarna, and Afterpay, removes the upfront cost barrier
+Medications sourced from FDA-registered 503B outsourcing facilities, stricter oversight than standard compounding

Cons

−Promo-dependent pricing, standard tirzepatide is $449/mo without discount, nearly double the promo price
−Select state availability only, not available nationwide
−Trustpilot rating flagged for potential review solicitation, verify independently

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Our Verdict

MEDVi edges out Elevate Health with a score of 7.7/10 vs 7.2/10. If budget is your priority, MEDVi starts at $179/mo compared to Elevate Health's $233/mo. Choose Elevate Health if you want: users who want financing options and free lab work with their glp-1 program. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither Elevate Health nor MEDVi feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review